The global Needle Free Drug Delivery Devices market is projected to reach USD 272 million by 2026, growing at a CAGR of 17%
The rising demand of such devices has augmented significantly, these devices helps to improve immune support to vaccines, reduce healthcare expenses, and get rid of risks of needles. Likewise, Minimal damage to skin, controlled dosing ability, and fast drug administration are some key factors driving the demand for global needle free drug delivery devices market over forecast period. These are some compensation associated with needle-free drug delivery devices are estimated to serve as main driving factors contributing the overall growth of the needle-free drug delivery devices market into coming years.
This report covers the detailed study of needle free drug delivery market analysis, trends, key players, and market growth during the forecast period. Report also focuses on different segmentations based on application, technology, and region.
Global needle free drug delivery devices market segmentation based on application, end-user, technology, and region. By technology, the market is classified into transdermal patch technology, inhaler technology, Oral drug delivery system, jet injectors, spring based needle free injectors, laser needle free injectors, novel needle free technologies, and others. Among these, the Jet injector segment was one of the largest market shares, in terms of revenue, owing to its increased usage rate and wide applicability in delivering a huge range of drugs.
Based on application, the global needle free drug delivery devices market segment detained the largest share in past years, owing to the increase demand for painless needle free drug delivery by patients with the necessity of such devices regularly in diabetic patients, consequently facilitating the expansion of global needle free drug delivery devices market.
On the basis of geography, the global needle-free drug delivery devices market is categorized into North America, Asia Pacific, Europe, and Rest of world. Among these, North America region held the highest share of global needle free drug delivery devices market, in 2016. This can be credited majorly owing to the high awareness of pharmaceutical and biologics drugs, growing popularity of chronic diseases, and rising number of R&D investments by major market players are driving the market growth over forecast period.
The increasing preference towards the self-administration of needle-free drugs, growing popularity of chronic disorders and decreased healthcare expenses are the major factors that contributing the growth of the market.
Needle Free Drug Delivery Devices Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2026||USD 272 million|
|Growth Rate||CAGR of 17% during 2021-2026|
|Segment Covered||Type of Medication, End Users, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and Africa|
|Key Players Profiled||Antares Pharma, 3M, and Injex Pharma AG. Some other key players are Verdict Media Limited; Pharmajet; Zonenix; Inovio Pharmaceuticals, Inc.; Valeritas, Inc.; Penjet.|
Global needle-free drug delivery devices market segmentation:
- Challenging Needle-Free Technologies
- Inhaler Technology
- Novel Needle-Free Technologies
- Transdermal Patch Technology
- Jet Injectors
- Pain Management
- Vaccine Delivery
- Pediatric Injections
- Insulin Delivery
- North America
- Asia Pacific
- Rest of ASPAC
- Rest of Europe
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
- Latin America
- Rest of Latin America